WhatsApp us
Request a Quote

Market research: Medical Devices

Orthopedic Implants Market in India: Size, Growth and Key Players

What published estimates say about India's orthopedic implant market, how price caps and incentives shape it, and which Indian companies are gaining share, with every figure sourced.

  • Every figure linked to its source
  • Published estimates compared, not picked
  • 150K+ clients in 85 countries since 1994

NPCS market research report

Orthopedic implant market in India

  • Market size and growth
  • Growth drivers and industry trends
  • Demand and supply situation
  • Foreign trade: imports and exports
  • Regulatory framework and recent changes
  • Porter's five forces analysis
See what the report covers
Published market size estimates
₹23,810 crore to ₹39,330 crore[15][16]
2 estimates, base years 2024 to 2025; USD figures converted at ₹95.25 per USD
Published forecasts
₹49,530 crore to ₹67,150 crore[15][16]
for 2034 to 2035
Yearly patient savings from knee implant price caps
₹1,500 crore a year[4]
Press Information Bureau (Department of Pharmaceuticals), Dec 2025
Key states
Gujarat, Maharashtra, Karnataka[5][14]
see the location section
Sources checked
17
8 official
Data as of
Nov 2026
Next review in 6 months

Figures come from the sources listed at the end of this page. Market sizes are published estimates by independent research firms and rating agencies, not NPCS figures.

Orthopedic implants market in India at a glance

The orthopedic implants market in India covers knee and hip replacements, trauma plates, screws and nails, and spine implants. Research firms estimate it at USD 2.5 billion for 2025 and USD 4,128.8 million for 2024. Government data show knee implant price caps save patients about ₹1,500 crore a year.

Hospitals, implant makers, importers and investors follow it, because price caps, PLI incentives and a rising group of Indian manufacturers are changing who supplies Indian surgeons.

Also searched as: orthopaedic implants market in India, orthopedic implants market size in India, knee implants market in India, orthopedic implant manufacturers in India.

How big is the orthopedic implants market in India?

No government body publishes a value for this market. Two research firms publish estimates, a year apart, and the higher one is well above the lower.

Published estimates of market size
Publisher and base yearEstimateForecast
Research firm A[15]2025, joint, spine, trauma and orthobiologic implants, and also dental implants; split by product, type, biomaterial and end userUSD 2.5 billionabout ₹23,810 croreUSD 5.2 billion by 2034CAGR 7.92% (2026 to 2034)
Research firm B[16]2024, spinal, reconstructive joint and orthobiologic implants; base year 2024; page gives the growth rate as both 4.9% and 4.98%USD 4,128.8 millionabout ₹39,330 croreUSD 7,050 million by 2035CAGR 4.98% (2025 to 2035)

Estimates are published by independent research firms and rating agencies and are not NPCS figures. Rupee equivalents of USD figures use ₹95.25 per USD (6 Nov 2026) and are shown only for comparison.

Why the estimates differ: Research firm B puts the market at USD 4,128.8 million for 2024, about 1.7 times Research firm A's USD 2.5 billion for 2025. Their scopes differ: A also counts dental implants, B counts orthobiologics, and neither publishes its method. CareEdge Ratings puts orthopaedic and cardiac implants together at about $2.4–2.7 billion in FY24, which sits closer to Research firm A.

Part of the gap is scope. Orthobiologics are the bone graft and healing products used with implants, and dental implants are a separate trade with different buyers.

The growth outlooks differ too. Research firm A projects USD 5.2 billion by 2034, growing 7.92% a year from 2026. Research firm B projects USD 7,050 million by 2035, at 4.98% a year.

Use both as rough guides for sizing. The firmer signals are official ones: knee price caps, PLI project data and the reported sales of named Indian makers.

Which orthopedic implant segments matter most in India?

Knee replacement gets the most attention, because NPPA caps knee implant prices. Hip and trauma implants and exports are the other parts with public data.

  • Knee replacement implants: Under an NPPA price cap since August 2017. Ceilings run from about ₹32,000 to ₹83,000 by type and material, according to CareEdge Ratings. About 1 to 1.5 lakh knee procedures a year were done in 2017.[3][6][12]
  • Hip, knee and trauma implants: Meril Healthcare's PLI project makes all three. It had ₹90.49 crore invested by September 2025, according to government data on the scheme.[5]
  • Exports: Indian medical implant exports grew 25% a year in the six years to FY24, and the largest domestic knee implant maker exports to over 150 countries.[12][13]

A knee system has a femoral component, a tibial tray and a plastic insert. Material sets the price band, and cobalt chromium is the most widely used knee, according to the 2017 PIB release.

Trauma fixation covers plates, screws and intramedullary nails for fractures. These need less design and wear testing than a full knee or hip system, so they suit a first product range.

Who are the key orthopedic implant companies in India?

Foreign brands led the market before COVID, but Indian companies are now winning share and capital. The table lists Indian players, each with a detail from an official, rating agency or exchange source.

CompanyWhat it doesListed
Meril (Micro Life Sciences group)[5][13]Largest domestic maker and seller of knee implants, per CareEdge; PLI project at Vapi with ₹90.49 crore invested and ₹564.46 crore exported by Sep 2025No
Biorad Medisys[14]About 10% of the domestic orthopedic implants market, per ICRA; revenue of ₹546.6 crore in FY2025; plants in Pune and BengaluruNo
Shalby (Shalby Medtech)[10]Hospital group whose implant manufacturing segment earned ₹13,129.20 lakh (about ₹131.29 crore) in FY2025-26Yes
Alkem Laboratories (Alkem Medtech)[9][12]Completed buying 100% of Bombay Ortho Industries in April 2025; named by CareEdge among firms investing in implant makingYes
Zydus Lifesciences[11][12]Agreed in April 2025 to buy 85.6% of Amplitude Surgical, a French maker of hip and knee implantsYes

Two drug makers moved in through deals in 2025. Alkem completed its purchase of Bombay Ortho Industries, and Zydus agreed to buy a French hip and knee specialist.

Imported brands still matter. When NPPA reviewed knee implant sales in 2020, 10 of the 14 major companies it covered were importers.

Revenue figures are for each company's whole business or implant segment, as reported, and can include exports and other products.

What drives orthopedic implant demand in India, and what holds it back?

An older population and wider insurance cover push demand up. Price caps and low import duty keep pressure on margins.

What drives demand

  • Sales of homegrown implant makers grew 28% a year over the four years to FY24, according to CareEdge[12]
  • CareEdge Ratings expects orthopaedic and cardiac implants together to grow from about $2.4–2.7 billion in FY24 to $4.5–5.0 billion by FY28[12]
  • Domestic makers' share of knee implants rose by 11% in the two years after the 2017 caps; 10 of the 14 major sellers NPPA reviewed in 2020 were importers[7]
  • CareEdge expects India's population aged 45 and above to grow by about 2.3% to 2.4% a year[12]
  • Total knee replacement is one of the main treatments claimed under Ayushman Vay Vandana, the cover for citizens aged 70 and above[8]
  • The PLI scheme for medical devices, which covers implants, now runs to 2035-36 with fresh applications open[1]

What holds it back

  • Knee implant prices have been capped since August 2017, and the latest order keeps the caps until 15 January 2027[3][17]
  • Foreign companies held more than 90% of the market by value before COVID, and most implant imports pay only 7.5% customs duty[12]

The knee cap cuts both ways. It limits margins on the busiest joint, yet domestic makers gained share after it began, which suggests the ceiling suits lower-cost local production.

Which rules shape the orthopedic implant market?

Three government measures matter most for buyers and makers: knee implant price ceilings, the PLI incentive scheme and a low import duty.

Knee implant price ceilings (NPPA)[4][6][17]Aug 2017Capped the most used cobalt chromium knee at ₹54,720 in 2017; caps renewed since, now to 15 January 2027, with savings of about ₹1,500 crore a year
PLI scheme for medical devices[1][12]Nov 2026Sales-linked incentives for devices made in India, with an outlay of ₹3,420 crore; extended to 2035-36, with implants in the first target segment
Customs duty on implants[12]May 2025Most orthopedic and coronary implant imports pay 7.5% duty, so imported brands face a low tariff

NPPA is the National Pharmaceutical Pricing Authority, the drug and device price regulator. PLI means production-linked incentive, a payout tied to extra sales of devices made in India.

For a new maker, the ceiling fixes what you can charge for a knee system. Material cost, machining yield and dealer margins then decide whether the product pays.

Where are orthopedic implants made in India?

Public records place the largest Indian makers in western and southern India.

  • Gujarat: Meril Healthcare's PLI project for hip, knee and trauma implants is registered at Vapi.[5]
  • Maharashtra: Biorad Medisys, about 10% of the domestic market per ICRA, makes implants in Pune.[14]
  • Karnataka: Biorad's second manufacturing facility is in Bengaluru.[14]

These are company locations taken from government and rating agency records. They are not a full map of the industry, only the makers with public records.

Recent developments in the orthopedic implants market

  1. NPPA extended knee implant ceiling prices by two months, to 15 January 2027, while it considers industry requests.[17]

  2. The government extended the PLI scheme for medical devices to 2035-36 and invited fresh applications, with implants in the first target segment.[1]

  3. NPPA's expert committee deferred a decision on a separate price band for cementless knee implants; Meril withdrew its request for its 3D-printed uncemented knee.[2]

  4. Zydus Lifesciences agreed to buy 85.6% of Amplitude Surgical, a French hip and knee implant company.[11]

  5. Alkem Medtech completed its purchase of 100% of Bombay Ortho Industries.[9]

Is there room for a new orthopedic implant unit in India?

Yes, for a maker that can meet device quality rules and sell within price caps. Sales of Indian implant makers grew 28% a year in the four years to FY24, and exports give a second outlet.

Trauma plates and screws are the usual starting range. Knee and hip systems need design data, wear testing and surgeon training, so they suit a later stage or a technology partner.

Related NPCS project reports cover nearby medical products:

How NPCS helps with orthopedic implant projects

  • Market research reportDemand, imports, price caps and company profiles for knee, hip, trauma and spine implants.
  • Product and segment choiceCompare trauma, joint and spine ranges by capital need, testing load and selling price.
  • Detailed project reportMachinery, clean room, plant cost and five-year projections for an implant unit.
  • Custom market surveySurgeon, hospital and distributor research for a product or state.

NPCS has helped launch businesses across 40+ sectors since 1994, serving 150K+ clients in 85 countries with 150K successful projects delivered.

What the NPCS orthopedic implant market report covers

  1. Market overview and definition
  2. Market size and growth
  3. Growth drivers and industry trends
  4. Demand and supply situation
  5. Foreign trade: imports and exports
  6. Regulatory framework and recent changes
  7. Porter's five forces analysis
  8. SWOT analysis
  9. Key player profiles with financials
  10. Shareholding pattern, revenue mix and plant locations

This page summarises public data. The full report adds company profiles, financials and the demand-supply analysis.

Request the report contents

Project reports for this industry

Planning a plant rather than studying the market? These NPCS project reports cover plant cost, machinery and profitability, each with a free illustrative sample.

How this page was researched

Each figure on this page is taken from a source we opened on the date shown, and the source is numbered in the list below. Government data comes first. Company figures come from company filings and documents, or from rating-agency sector notes.

Market size estimates are published by research firms and rating agencies. They often disagree, because they define the market differently or use different base years. We show them side by side instead of choosing one. Rupee equivalents of US dollar figures use ₹95.25 per USD and are for comparison only.

NPCS does not add its own forecasts to this page. The page is reviewed every 6 months, or sooner when a major data release or policy change comes out.

Orthopedic implants market in India: frequently asked questions

What is the size of the orthopedic implants market in India?

There is no official figure. One research firm estimates the market at USD 2.5 billion for 2025, and another puts it at USD 4,128.8 million for 2024. The second figure is about 1.7 times the first. Their scopes differ and neither publishes its method, so treat both estimates as rough guides rather than a settled size.

What is the growth rate of the orthopedic implants market in India?

Published forecasts range from 4.98% to 7.92% a year. One research firm projects USD 5.2 billion by 2034, and another projects USD 7,050 million by 2035. CareEdge Ratings takes a wider view and expects orthopaedic and cardiac implants together to reach $4.5–5.0 billion by FY28, growing around 15–16% a year.

Are knee implant prices controlled in India?

Yes. NPPA has capped knee implant prices since August 2017, and its latest order keeps the caps until 15 January 2027. Ceilings run from about ₹32,000 to ₹83,000 per implant, according to CareEdge Ratings. The government estimates that the caps save patients about ₹1,500 crore a year.

Who are the leading orthopedic implant manufacturers in India?

Meril, part of the Micro Life Sciences group, is the largest domestic maker and seller of knee implants, according to CareEdge Ratings. ICRA estimates that Biorad Medisys holds about 10% of the domestic market. Shalby makes implants alongside its hospitals, and Alkem and Zydus entered the field through acquisitions in 2025.

How much of the Indian orthopedic implant market is imported?

No official import share is published for orthopedic implants alone. CareEdge Ratings says foreign companies held more than 90% of the orthopaedic and cardiac implant market by value before COVID. Most implant imports pay only 7.5% customs duty, although domestic makers' share of knee implants rose by 11% in the two years after the 2017 price caps.

Does the PLI scheme cover orthopedic implants?

Yes. Implants fall in the first target segment of the PLI scheme for medical devices, which now runs to 2035-36 with fresh applications open. Meril Healthcare's PLI project for hip, knee and trauma implants at Vapi had ₹90.49 crore invested by September 2025, according to government data on the scheme.

What does the NPCS orthopedic implant report add to this page?

This page summarises public data and published estimates. The NPCS report adds company profiles with financials, demand and supply analysis, foreign trade, the regulatory framework and a SWOT analysis. It suits investors, lenders and companies planning an implant unit or an entry into India. Ask for the report contents and price through the enquiry form.

Sources

  1. Govt invites fresh applications under PLI scheme for medical devicesAll India Radio News (Prasar Bharati), Official, checked Nov 2026
  2. Minutes of the 75th Multidisciplinary Committee of Experts meetingNational Pharmaceutical Pricing Authority, Official, checked Nov 2026
  3. Issue of high trade margins in essential medical devicesPress Information Bureau (Department of Pharmaceuticals), Official, checked Nov 2026
  4. Measures to prevent overpricing and unethical practicesPress Information Bureau (Department of Pharmaceuticals), Official, checked Nov 2026
  5. Progress and implementation of the PLI scheme for medical devicesPress Information Bureau (Department of Pharmaceuticals), Official, checked Nov 2026
  6. Government fixes ceiling prices of Knee Implants; People of India to save Rs.1500 crore per annumPress Information Bureau (Ministry of Chemicals and Fertilizers), Official, checked Nov 2026
  7. NPPA extends ceiling prices of Knee Implants till 14th September 2021Press Information Bureau (Ministry of Chemicals and Fertilizers), Official, checked Nov 2026
  8. Advancing Universal and Inclusive Senior Care: Ayushman Vay Vandana Marks Two YearsPress Information Bureau (Ministry of Health and Family Welfare), Official, checked Nov 2026
  9. Alkem Laboratories: completion of acquisition of Bombay Ortho IndustriesAlkem Laboratories Limited (NSE filing), Company filings, checked Nov 2026
  10. Shalby Limited audited consolidated results for the year ended 31 March 2026Shalby Limited (NSE filing), Company filings, checked Nov 2026
  11. Zydus Lifesciences signs purchase agreement to acquire a majority stake in Amplitude Surgical SAZydus Lifesciences Limited (stock exchange filing), Company filings, checked Nov 2026
  12. India's Orthopaedic and Cardiac Implant Sector Poised to Touch $5 Billion by FY28CareEdge Ratings, Industry bodies and rating agencies, checked Nov 2026
  13. Merai Newage Private Limited: rating press releaseCareEdge Ratings, Industry bodies and rating agencies, checked Nov 2026
  14. Biorad Medisys Private Limited: rating rationaleICRA, Industry bodies and rating agencies, checked Nov 2026
  15. Published market estimate (Research firm A)Independent research firm, not named or linked, checked Nov 2026
  16. Published market estimate (Research firm B)Independent research firm, not named or linked, checked Nov 2026
  17. NPPA Extends Knee Implant Price Caps Until January 2027Medical Dialogues (NPPA order of 13 November 2026), News and trade press, checked Nov 2026

Estimates from independent research firms are shown as Research firm A, B and so on, without the firm's name or a link.

Ajay Kumar Gupta, founder of NPCS

Who researches NPCS market pages

The NPCS project team, led by Ajay Kumar Gupta

Market research pages are researched and reviewed by the NPCS project team, which has prepared market surveys and techno-economic feasibility studies since 1994.

Countries served
85
Clients served
150K+
Successful projects delivered
150K
Years in consulting
30+

NPCS has helped launch businesses across 40+ sectors since 1994

Ajay Kumar Gupta founded Niir Project Consultancy Services (NPCS) in 1994 and leads the organisation. Under his leadership NPCS has served 150K+ clients in 85 countries and delivered 150K projects across 40+ sectors.

Ajay Kumar Gupta on LinkedIn

Published
Last updated
Next review
May 2027
Reviewed by
NPCS project team

Data as of Nov 2026. If you spot a newer official figure, tell us and we will check it.

Get the orthopedic implant market report

Tell us what you need the research for: a new plant, an investment decision, a bank or board note. Our team will send the report contents and price.

NPCS also prepares custom market surveys for a product, region or buyer group.

Request the Orthopedic Implant Market Report

Share your requirement and our team will call you back within 24 hours.

Need more than public data?

The NPCS report on the orthopedic implant market adds company profiles, financials and a demand-supply view for planning and investment decisions.

Request contents WhatsApp
Call Us WhatsApp